U.S. Markets closed

Senzime AB (publ) (SEZI.ST)

Stockholm - Stockholm Real Time Price. Currency in SEK
12.04-0.20 (-1.63%)
At close: 05:29PM CET

Senzime AB (publ)

Ulls vAeg 41
Uppsala 756 51
46 18 51 56 40

IndustryMedical Devices
Full Time Employees29

Key Executives

NameTitlePayExercisedYear Born
Ms. Pia RenaudinChief Exec. Officer2.81MN/A1967
Mr. Slavoljub GrujicicChief Financial OfficerN/AN/A1970
Ms. Johanna TulkkiCOO & Interim Chief Technology OfficerN/AN/A1970
Ms. Rianne Lundqvist Waninge Ph.D.Application ScientistN/AN/AN/A
Mr. Anders SelinVP of Global SalesN/AN/A1962
Mr. Anders JacobsonChief Innovation OfficerN/AN/A1967
Ms. Catrin MolundExec. VP & Bus. Devel.N/AN/A1970
Mr. Christopher J. EstesPres & GM of Senzime, Inc.N/AN/A1969
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.


Senzime AB (publ), a medical device company, develops and markets patient monitoring systems to monitor patients under anesthesia in Europe, Oceania, Asia, Canada, and the United States. The company offers TetraGraph, a monitor that stimulates, measures, analyzes, and displays muscle function in surgical patients receiving neuromuscular blocking agents; TetraSens electrode array, which has two proximal stimulating electrodes for recording and reference; TetraConnect, a data management portal that helps clinician to access, view, and export data records from the TetraGraph in PDF or Excel format; TetraGraph Device Connectivity, which transfers data from the TetraGraph Monitor to patient monitoring systems; and TetraGraph Philips Interface that enables the transmission of neuromuscular monitoring parameters, TOFC, TOFR, PTC, and TOF bars to Philips patient monitors, as well as TetraGraph readings are displayed on the Philips Intellivue Monitor. It also develops CliniSenz Analyzer for postoperative and continuous patient monitoring in hospital environments; and Onzurf Probe, a sterile CE-marked single use product based on micro-dialysis technology that enables continuous sampling from gastro-intestinal organs, such as esophagus, stomach, and liver. Senzime AB (publ) has a strategic license and connectivity agreement with Masimo to develop and market the TetraGraph Smart Cable Module that connects directly to Root monitoring system, as well as to their digital hubs to interface with the hospital clinical information system/electronic health records. The company was incorporated in 1999 and is based in Uppsala, Sweden.

Corporate Governance

Senzime AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.